Evidence map›Paper›PMID 31483883›Full record

ArticleClinical endocrinology2019

Impact of ultrasonographic features, cytomorphology and mutational testing on malignant and indeterminate thyroid nodules on diagnostic accuracy of fine needle cytology samples: A prospective analysis of 141 patients.

Franco Fulciniti, Anna Cipolletta Campanile, Maria Gabriella Malzone, Maria Grazia Chiofalo, Anna Capiluongo, Mario Monaco, Nunzia Di Maio, Fabio Sandomenico, Gerardo Botti, Gennaro Chiappetta and 2 more

Abstract read
In one paragraph

Article in Clinical endocrinology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Franco FulcinitiClinical Cytopathology Service, Istituto Cantonale di Patologia, Locarno, Switzerland.ORCID 0000-0002-4244-1109
Anna Cipolletta CampanileCytohistopathology Laboratory, Istituto Diagnostico Varelli, Naples, Italy.
Maria Gabriella MalzonePathological Anatomy Laboratory, Casa di Cura Maria Rosaria, Naples, Italy.
Maria Grazia ChiofaloThyroid and Parathyroid Surgery Unit, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.
Anna CapiluongoFunctional Genomics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.
Mario MonacoFunctional Genomics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.
Nunzia Di MaioMedical Center Oplonti (C.M.O), Naples, Italy.
Fabio SandomenicoRadiology Unit, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.
Gerardo BottiScientific Directorate, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.
Gennaro ChiappettaMedical Center Oplonti (C.M.O), Naples, Italy.
Emilia VuttarielloFunctional Genomics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.ORCID 0000-0002-9844-5731
Luciano PezzulloThyroid and Parathyroid Surgery Unit, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveFine needle cytology (FNC) is the first-line diagnostic method to determine the benign or malignant nature of thyroid nodules. The gray zone of cytological classifications remains, however, a crucial and challenging area for cytopathologists. DESIGN, PATIENTS AND MEASUREMENTS: In the present study, 141 thyroid cytological samples, with ultrasonographic suspicious features, have been prospectively analysed. Molecular analyses were performed by an innovative technology using two multiplex PCRs for the amplification of BRAF, N-H-K-RAS and RET exon genes. RNA samples were studied for RET/PTC1 and RET/PTC3 rearrangements by PCR amplification, and the conditions were set-up to study, with a single experiment, both wild-type PAX8 and PAX8/PPARɣ rearrangements. In total, 111 samples were examined for BRAF, N-H-KRAS and RET genes. An ultrasonographic, cytological and molecular correlation was also carried out in an attempt to suggest a possible way to manage the patients with thyroid nodules. Cyto-histological correlation was available in 115 cases, and it was used to verify the global diagnostic accuracy of this combined approach.

resultsAccording to the histopathological diagnosis, FNC accuracy was 100% for TIR5 and metastases; 89% for TIR4; 84% for TIR3A and 58% for TIR3B. About 11% of the studied samples showed either RET-PTC1 or RET/PTC3 chromosomal rearrangements, and only one sample simultaneously presented RET/PTC1 and RET/PTC3 rearrangements. PAX8/PPARɣ rearrangement was found in 6% of the samples.

conclusionsA multidisciplinary approach to the thyroid is therefore necessary to develop innovative methods suitable for an improved diagnostic and prognostic definition of thyroid cancer.

Indexed as

AdolescentAdultAgedAged, 80 and overBiopsy, Fine-NeedleDNA Mutational AnalysisExonsFemaleHumansMaleMiddle AgedPAX8 Transcription FactorProspective StudiesProto-Oncogene Proteins B-rafThyroid Cancer, PapillaryThyroid NeoplasmsPAX8 protein, humanPAX8 Transcription FactorProto-Oncogene Proteins B-rafcyto-histological correlationfine needle cytologyindeterminate nodulesmutational analysispapillary thyroid carcinomathyroid cancer treatmentultrasound features

Identifiers

PMID31483883
PMCPMC6972562

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.